comparemela.com

Latest Breaking News On - Matthew zorn - Page 2 : comparemela.com

A Drug Test Cost a DEA Agent His Job. He Sued and Got It Back.

The Drug Enforcement Administration regarded Anthony Armour as an “outstanding” special agent on the front lines of the nation’s opioid epidemic. But in 2019, a routine drug test derailed his career. Months earlier, Armour said he had begun using CBD oil, which is derived from hemp, to treat chronic pain, deeming it safer than the highly addictive painkillers that were the focus of his criminal investigations. His failed drug test led the government to fire him, setting off a lengthy court battl

Houston
Texas
United-states
New-york
Matthew-zorn
Anthony-armour
Drug-administration
New-york-times
York-times-company
Drug-enforcement-administration
Department-of-justice
Anthony

A drug test cost a DEA agent his job. He sued and got it back.

The Drug Enforcement Administration regarded Anthony Armour as an “outstanding” special agent on the front lines of the nation’s opioid epidemic. But in 2019, a routine drug test derailed his career.

New-york
United-states
Houston
Texas
Matthew-zorn
Department-of-justice
Anthony
New-york-times
Drug-administration
Justice-department
World-health-organization
Will-glaspy

DEA Considers Rescheduling Cannabis—What This Means For U.S. And Global Reform

The DEA has confirmed its review into the rescheduling of cannabis, as health officials release hundreds of documents acknowledging its medical use.

Germany
United-states
Maryland
Colorado
District-of-columbia
Illinois
Punchbowl
New-york
Louisiana
New-jersey
Americans
German

FDA Recommends DEA Move Cannabis to Schedule III

Newly released documents show that the FDA has determined that cannabis has legitimate medical use and that it should be moved from Schedule I to Schedule III on the controlled substances list.

Oklahoma
United-states
Washington
Houston
Texas
Americans
James-lankford
Anne-milgram
Shane-pennington
Joe-biden
Howard-sklamberg
Porter-wright

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.